FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1570800134> ?p ?o ?g. }

• W1570800134 endingPage "29" @default.
• W1570800134 startingPage "19" @default.
• W1570800134 abstract "The DNA repair host-mediated assay was further calibrated by testing 7 chemotherapeutic agents known to possess carcinogenic activity, namely bleomycin (BLM), cis-diamminedichloroplatinum-II (cis-Pt), cyclophosphamide (CP), diethylstilboestrol (DES), isonicotinic acid hydrazide (isoniazid, INH), natulan (NAT) and mitomycin C (MMC). Differential survival of wild-type and uvrB/recA E. coli strains served as a measure of genotoxic activity. In in vitro assays, BLM, cis-Pt and MMC exhibited high genotoxic activity. The other 4 compounds had no measurable effect on the survival of the two strains, either with or without mouse liver preparations. In the host-mediated assays BLM, cis-Pt, MMC and also NAT induced strong killing of the DNA repair-deficient bacteria recovered from liver, spleen, lungs, kidneys and the blood of treated mice compared to the wild-type strain. The results are not indicative of large organ-specific differences in genotoxically active amounts of the drugs immediately after their application to the host animals. CP, INH and DES did not show geneotix activity in these assays even at very high exposure levels. To compare the genetic endpoint measured in the DNA repair assays, i.e. induction of repairable DNA damage, with the induction of gene mutations, the ability of the 7 drugs to induce valine-resistant (VALr) mutants in E. coli was measured in host-mediated assays under identical treatment conditions. INH showed considerable mutagenic activity in E. coli cells recovered from liver and spleen, while BLM and MMC induced a 3–4-fold increase in VALr mutants above spontaneous levels. The other compounds showed no mutagenic activity under these in vivo conditions. From these results it can be concluded that (i) the type of primary DNA lesions produced by these chemotherapeutic agents (cross-links by MMC and cis-Pt, and strand breaks by BLM and possibly by NAT; base alkylation by INH) appears to determine whether a compound will be highly positive in the DNA repair assay as in the case of BLM, cis-Pt, MMC and NAT, and less effective in inducing mutations under similar conditions, or whether the opposite will occur, as in the case of INH; (ii) DES and CP probably do not interact sufficiently with bacterial DNA to show an effect in either of the genetic endpoints; and (iii) the present DNA repair host-mediated assay may represent a sensitive, rapid and economic method for monitoring genotoxic factors in various organs of experimental animals which have been treated with cytostatic drugs." @default.
• W1570800134 created "2016-06-24" @default.
• W1570800134 creator A5006150337 @default.
• W1570800134 creator A5035140015 @default.
• W1570800134 creator A5051473451 @default.
• W1570800134 creator A5089409380 @default.
• W1570800134 date "1986-02-01" @default.
• W1570800134 modified "2023-09-27" @default.
• W1570800134 title "Evaluation of the DNA repair host-mediated assay" @default.
• W1570800134 cites W1495393562 @default.
• W1570800134 cites W1506983576 @default.
• W1570800134 cites W1507507742 @default.
• W1570800134 cites W15668822 @default.
• W1570800134 cites W1595459790 @default.
• W1570800134 cites W1607372108 @default.
• W1570800134 cites W1775749144 @default.
• W1570800134 cites W1965399614 @default.
• W1570800134 cites W1975795607 @default.
• W1570800134 cites W1982518329 @default.
• W1570800134 cites W1988449046 @default.
• W1570800134 cites W1988575749 @default.
• W1570800134 cites W1990212026 @default.
• W1570800134 cites W1999767122 @default.
• W1570800134 cites W2001740892 @default.
• W1570800134 cites W2008790155 @default.
• W1570800134 cites W2011631604 @default.
• W1570800134 cites W2015348602 @default.
• W1570800134 cites W2016480220 @default.
• W1570800134 cites W2021415766 @default.
• W1570800134 cites W2023726022 @default.
• W1570800134 cites W2024991413 @default.
• W1570800134 cites W2025467703 @default.
• W1570800134 cites W2030662954 @default.
• W1570800134 cites W2032653428 @default.
• W1570800134 cites W2034198381 @default.
• W1570800134 cites W2038214500 @default.
• W1570800134 cites W2048208481 @default.
• W1570800134 cites W2050350173 @default.
• W1570800134 cites W2055353720 @default.
• W1570800134 cites W2058091604 @default.
• W1570800134 cites W2067792968 @default.
• W1570800134 cites W2070632671 @default.
• W1570800134 cites W2082207259 @default.
• W1570800134 cites W2083103296 @default.
• W1570800134 cites W2084609367 @default.
• W1570800134 cites W2158927142 @default.
• W1570800134 cites W2312951677 @default.
• W1570800134 cites W2332836093 @default.
• W1570800134 cites W2413951821 @default.
• W1570800134 doi "https://doi.org/10.1016/0165-1161(86)90038-5" @default.
• W1570800134 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/2419750" @default.
• W1570800134 hasPublicationYear "1986" @default.
• W1570800134 type Work @default.
• W1570800134 sameAs 1570800134 @default.
• W1570800134 citedByCount "9" @default.
• W1570800134 countsByYear W15708001342012 @default.
• W1570800134 countsByYear W15708001342015 @default.
• W1570800134 crossrefType "journal-article" @default.
• W1570800134 hasAuthorship W1570800134A5006150337 @default.
• W1570800134 hasAuthorship W1570800134A5035140015 @default.
• W1570800134 hasAuthorship W1570800134A5051473451 @default.
• W1570800134 hasAuthorship W1570800134A5089409380 @default.
• W1570800134 hasConcept C104317684 @default.
• W1570800134 hasConcept C134935766 @default.
• W1570800134 hasConcept C143065580 @default.
• W1570800134 hasConcept C143425029 @default.
• W1570800134 hasConcept C153911025 @default.
• W1570800134 hasConcept C185592680 @default.
• W1570800134 hasConcept C203014093 @default.
• W1570800134 hasConcept C2779338040 @default.
• W1570800134 hasConcept C2780931953 @default.
• W1570800134 hasConcept C54355233 @default.
• W1570800134 hasConcept C552990157 @default.
• W1570800134 hasConcept C55493867 @default.
• W1570800134 hasConcept C86803240 @default.
• W1570800134 hasConceptScore W1570800134C104317684 @default.
• W1570800134 hasConceptScore W1570800134C134935766 @default.
• W1570800134 hasConceptScore W1570800134C143065580 @default.
• W1570800134 hasConceptScore W1570800134C143425029 @default.
• W1570800134 hasConceptScore W1570800134C153911025 @default.
• W1570800134 hasConceptScore W1570800134C185592680 @default.
• W1570800134 hasConceptScore W1570800134C203014093 @default.
• W1570800134 hasConceptScore W1570800134C2779338040 @default.
• W1570800134 hasConceptScore W1570800134C2780931953 @default.
• W1570800134 hasConceptScore W1570800134C54355233 @default.
• W1570800134 hasConceptScore W1570800134C552990157 @default.
• W1570800134 hasConceptScore W1570800134C55493867 @default.
• W1570800134 hasConceptScore W1570800134C86803240 @default.
• W1570800134 hasIssue "1" @default.
• W1570800134 hasLocation W15708001341 @default.
• W1570800134 hasLocation W15708001342 @default.
• W1570800134 hasOpenAccess W1570800134 @default.
• W1570800134 hasPrimaryLocation W15708001341 @default.
• W1570800134 hasRelatedWork W1746630368 @default.
• W1570800134 hasRelatedWork W1914298319 @default.
• W1570800134 hasRelatedWork W1975810432 @default.
• W1570800134 hasRelatedWork W1975936119 @default.
• W1570800134 hasRelatedWork W2036958281 @default.

• next